card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Genomic Profiling of Late Stage Tumors Powering Precision Medicine in Japan

Home / Insights / Genomic Profiling of Late Stage Tumors Powering Precision Medicine in Japan

Genomic profiling of tumors provides patients with treatment options specific to their tumor’s biology.  Download this scientific poster presented at AACR 2016 Annual Meeting and learn how genomic profiling with IQVIA LaboratoriesComprehensive Cancer Panel helps to inform treatment options for cancer patients in Japan.

Experts: Masashi Kanai1, Matthew Schu2, Tomohiro Sakuma3, Steven Abbott2, Tadayuki Kou1, Ross Gagnon2, Thomas Halsey2, Shigemi Matsumoto1, Mayumi Kamada4, Masahiko Nakatsui4, Yasushi Okuno4, Akinori Hiroshima3, Hiroaki Mochizuki3Patrick Hurban2, Manabu Muto1Victor J. Weigman, Jr.2 

1Dept. of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan;
Q2 Solutions Company, Morrisville, NC; 
3Biomedical Dept., Mitsui Knowledge Industry co., ltd, Toyko, Japan; 
4Department of Clinical System Onco-Informatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Complete the form below to access this scientific poster